PaoloDepetrilloMD
Internal Medicine • Baltimore, MDClinical Pharmacology
Vice President, Clinical Research
Dr. Depetrillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 W Baltimore St
Fl 5
Baltimore, MD 21201Phone+1 443-794-8333Fax+1 410-706-8963- Is this information wrong?
Education & Training
Roger Williams Medical CenterResidency, Internal Medicine, 1981 - 1984
The Warren Alpert Medical School of Brown UniversityClass of 1981
Certifications & Licensure
MD State Medical License 2013 - 2024
MA State Medical License 1985 - 2021
RI State Medical License 1984 - 2020- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD Start of enrollment: 2015 Dec 22
- Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers Start of enrollment: 2018 Apr 06
- A Study to Evaluate the Intramuscular Administration of Scopolamine Start of enrollment: 2020 Jun 02
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsHow Much Data Is Enough? A Reliable Methodology to Examine Long-Term Wearable Data Acquisition in Gait and Postural Sway.Brett M Meyer, Paolo Depetrillo, Jaime Franco, Nicole Donahue, Samantha R Fox, Aisling O'Leary, Bryn C Loftness, Reed D Gurchiek, Maura Buckley, Andrew J Solomon, Sau ...> ;Sensors. 2022 Sep 15
- 6 citationsRelative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized...Paul Dorinsky, Paolo DePetrillo, Kiernan DeAngelis, Roopa Trivedi, Patrick Darken, Michael Gillen> ;Clinical Therapeutics. 2020 Apr 1
- 10 citationsPharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (B...Andrea Maes, Paolo DePetrillo, Shahid Siddiqui, Colin Reisner, Paul Dorinsky> ;Clinical Pharmacology in Drug Development. 2019 Feb 1
- Join now to see all
Grant Support
- Monitoring Of Heart Rate Variability During Alcohol Withdrawal SyndromeNational Institute On Alcohol Abuse And Alcoholism1996–1997
- Interaction Of Ethyl Alcohol With Cellular Cysteine ProteasesNational Institute On Alcohol Abuse And Alcoholism1996–1997
External Links
- Pharmaronhttp://pharmaron.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
